Skip to main content
. Author manuscript; available in PMC: 2020 Jan 10.
Published in final edited form as: Eur J Clin Nutr. 2019 Jun 26;74(1):87–96. doi: 10.1038/s41430-019-0460-7

Table 2.

HR and 95% CI for All-Cause Mortality by γ-Tocopherol Quartiles

γ-Tocopherol Quartiles (μg/mL) Median (μg/mL) Participants (N) Deaths (N) HR (95% CI)a Ptrenda
Men
Model 1b
Q1 (0.27–1.17) 0.96 973 198 1.00
Q2 (1.17–1.63) 1.39 974 211 1.18 (0.97–1.43)
Q3 (1.63–2.28) 1.92 968 223 1.25 (1.02–1.52)
Q4 (2.28–11.02) 2.86 972 237 1.43 (1.17–1.74) 0.0005
Model 2c
Q1 (0.27–1.17) 0.96 971 192 1.00
Q2 (1.17–1.63) 1.39 968 209 1.12 (0.92–1.38)
Q3 (1.63–2.28) 1.92 960 220 1.23 (1.00–1.50)
Q4 (2.28–11.02) 2.86 963 235 1.15 (0.93–1.41) 0.23
Model 3d
Q1 (0.27–1.17) 0.96 973 198 1.00
Q2 (1.17–1.63) 1.39 974 211 1.16 (0.96–1.42)
Q3 (1.63–2.28) 1.92 968 223 1.23 (1.01–1.49)
Q4 (2.28–11.02) 2.86 972 237 1.34 (1.09–1.63) 0.006
Women
Model 1b
Q1 (0–1.17) 0.97 1113 136 1.00
Q2 (1.17–1.66) 1.40 1112 139 1.06 (0.84–1.35)
Q3 (1.66–2.39) 1.98 1114 138 1.11 (0.87–1.41)
Q4 (2.39–13.97) 2.98 1113 181 1.58 (1.25–2.00) <0.0001
Model 2c
Q1 (0–1.17) 0.97 1110 136 1.00
Q2 (1.17–1.66) 1.40 1106 139 1.03 (0.81–1.32)
Q3 (1.66–2.39) 1.98 1101 137 1.04 (0.82–1.34)
Q4 (2.39–13.97) 2.98 1110 179 1.38 (1.08–1.75) 0.005
Model 3d
Q1 (0–1.17) 0.97 1113 136 1.00
Q2 (1.17–1.66) 1.40 1112 139 1.07 (0.85–1.37)
Q3 (1.66–2.39) 1.98 1114 138 1.07 (0.84–1.36)
Q4 (2.39–13.97) 2.98 1113 181 1.45 (1.14–1.83) 0.001
a

HR, 95% CI and P values were estimated by Cox proportional hazards models.

b

Model 1: Adjusted by Cox regression for age at blood draw, race/ethnicity (as a strata variable) and serum cholesterol levels.

c

Model 2: Adjusted by Cox regression for variables in Model 1, and further adjusted for history of cancer, cardiovascular diseases, diabetes, and hypertension and smoking related variables.

d

Model 3: Adjusted by Cox regression for variables in Model 1, and further adjusted for C-reactive protein (log-transformed).